Cargando…

Relapse of neuromyelitis optica spectrum disorder after BNT162b2 mRNA Covid-19 vaccination

Detalles Bibliográficos
Autores principales:	Wang, Qi, Kang, Jin-Ju, Bai, Yutong, Oh, Sun-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024163/ https://www.ncbi.nlm.nih.gov/pubmed/36941823 http://dx.doi.org/10.1016/j.ensci.2023.100455

Ejemplares similares

First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2
por: Umezawa, Shu, et al.
Publicado: (2022)

A Case Presenting with Neuromyelitis Optica Spectrum Disorder and Infectious Polyradiculitis Following BNT162b2 Vaccination and COVID-19
por: Kim, Youngho, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis
por: Seok, Hung Youl, et al.
Publicado: (2018)

Eculizumab in the treatment of neuromyelitis optica spectrum disorder
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Relapse After Cessation of Immunosuppressants in Seropositive Neuromyelitis Optica Spectrum Disorder With Long-Term Remission
por: Seok, Jin Myoung, et al.
Publicado: (2021)

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
por: Uzawa, Akiyuki, et al.
Publicado: (2011)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
por: Kessler, Remi A., et al.
Publicado: (2016)

Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
por: Chatterton, Sophie, et al.
Publicado: (2022)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine
por: Juddoo, Vanessa, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder in a Patient with Ankylosing Spondylitis
por: Jeong, Soo, et al.
Publicado: (2018)

Neuromyelitis Optica Spectrum Disorder with Vertical Gaze Palsy and Hypersomnolence
por: Mathew, Jomal, et al.
Publicado: (2019)

Subacute Myelopathy: Think Beyond Neuromyelitis Optica Spectrum Disorder
por: Kasinathan, Ananthanarayanan, et al.
Publicado: (2019)

Cortical Blindness: An Unusual Manifestation of Neuromyelitis Optica Spectrum Disorder
por: Reddy Nagireddy, Ram Bhupal, et al.
Publicado: (2022)

Bilateral anterior uveitis after BNT162b2 mRNA vaccine: Case report
por: Duran, M.
Publicado: (2022)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
por: Özçelik, Pınar, et al.
Publicado: (2017)

Relapse of neuromyelitis optica associated with oral progestin
por: Li, Li-Min, et al.
Publicado: (2018)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Spectrum of sublytic astrocytopathy in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2021)

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder
por: Sherman, Elena, et al.
Publicado: (2015)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)

Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
por: Yanay, Noa Berar, et al.
Publicado: (2021)

COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus
por: Paschou, Stavroula A., et al.
Publicado: (2022)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Recurrent hiccups in COVID-19 forme fruste of neuromyelitis optica spectrum disorder?
por: Shubhakaran, Khichar P.
Publicado: (2022)

Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders
por: Shu, Yaqing, et al.
Publicado: (2016)

Naive B cells in neuromyelitis optica spectrum disorders: impact of steroid use and relapses
por: Janssen, Malou, et al.
Publicado: (2020)

Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders
por: Zhang, Shanchao, et al.
Publicado: (2022)

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
por: Jagtap, Sujit Abajirao, et al.
Publicado: (2015)

Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019)

Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
por: Kong, Lingyao, et al.
Publicado: (2022)

Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder with cholangiocarcinoma: Casual or causal association?
por: Fang, Wei, et al.
Publicado: (2022)

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2012)

Sleep abnormality in neuromyelitis optica spectrum disorder
por: Song, Yijun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bgalevsui0qvght5h3603gek5d